X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-20 | BTAI | Yocca Frank | Chief Scientific Officer | S - Sale+OE | $1.09 | -6,845 | 26,175 | -21% | -$7,427 | |||||
| D | 2026-05-20 | BTAI | Rodriguez Javier | See Remarks | S - Sale+OE | $1.08 | -6,560 | 26,803 | -20% | -$7,111 | |||||
| D | 2026-05-20 | BTAI | Steinhart Richard I | CFO | S - Sale+OE | $1.09 | -6,845 | 26,300 | -21% | -$7,427 | |||||
| D | 2026-05-20 | BTAI | Mehta Vimal | CEO, Pres | S - Sale+OE | $1.09 | -19,419 | 550,066 | -3% | -$21,108 | |||||
| D | 2024-12-16 | BTAI | O'Neill Vincent | See Remarks | S - Sale+OE | $0.35 | -165 | 19,957 | -1% | -$58 | |||||
| D | 2024-12-16 | BTAI | Mehta Vimal | CEO, Pres, 10% | S - Sale+OE | $0.36 | -3,117 | 7,747,106 | 0% | -$1,131 | |||||
| D | 2024-12-16 | BTAI | Steinhart Richard I | CFO | S - Sale+OE | $0.36 | -577 | 20,932 | -3% | -$207 | |||||
| D | 2024-12-16 | BTAI | Rodriguez Javier | See Remarks | S - Sale+OE | $0.36 | -430 | 24,423 | -2% | -$153 | |||||
| D | 2024-12-16 | BTAI | Yocca Frank | Chief Scientific Officer | S - Sale+OE | $0.35 | -430 | 28,931 | -1% | -$152 | |||||
2024-10-03 | BTAI | Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | S - Sale | $0.55 | -6,272 | 19,011 | -25% | -$3,450 | ||||||
2024-10-03 | BTAI | Rodriguez Javier | See Remarks | S - Sale | $0.55 | -6,863 | 23,770 | -22% | -$3,775 | ||||||
2024-10-03 | BTAI | Yocca Frank | Chief Scientific Officer | S - Sale | $0.55 | -7,175 | 28,278 | -20% | -$3,946 | ||||||
2024-10-03 | BTAI | Steinhart Richard I | CFO | S - Sale | $0.55 | -7,175 | 20,279 | -26% | -$3,946 | ||||||
2024-10-03 | BTAI | O'Neill Vincent | See Remarks | S - Sale | $0.55 | -5,556 | 19,601 | -22% | -$3,056 | ||||||
| D | 2024-09-16 | BTAI | Yocca Frank | Chief Scientific Officer | S - Sale+OE | $0.69 | -355 | 14,203 | -2% | -$245 | |||||
| D | 2024-09-16 | BTAI | Mehta Vimal | CEO, Pres, 10% | S - Sale+OE | $0.69 | -1,982 | 7,739,167 | 0% | -$1,367 | |||||
| D | 2024-09-16 | BTAI | Steinhart Richard I | CFO | S - Sale+OE | $0.69 | -356 | 6,204 | -5% | -$246 | |||||
| D | 2024-09-16 | BTAI | Rodriguez Javier | See Remarks | S - Sale+OE | $0.69 | -345 | 9,133 | -4% | -$238 | |||||
| D | 2024-09-16 | BTAI | O'Neill Vincent | See Remarks | S - Sale+OE | $0.69 | -138 | 3,907 | -3% | -$95 | |||||
| D | 2024-09-16 | BTAI | Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $0.69 | -215 | 4,033 | -5% | -$149 | |||||
| D | 2024-06-17 | BTAI | Yocca Frank | Chief Scientific Officer | S - Sale+OE | $1.28 | -372 | 13,474 | -3% | -$476 | |||||
| D | 2024-06-17 | BTAI | Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $1.26 | -244 | 3,498 | -7% | -$308 | |||||
| D | 2024-06-17 | BTAI | Steinhart Richard I | CFO | S - Sale+OE | $1.26 | -372 | 5,476 | -6% | -$470 | |||||
| D | 2024-06-17 | BTAI | Rodriguez Javier | See Remarks | S - Sale+OE | $1.26 | -361 | 8,394 | -4% | -$456 | |||||
| D | 2024-06-17 | BTAI | O'Neill Vincent | See Remarks | S - Sale+OE | $1.29 | -155 | 3,524 | -4% | -$199 | |||||
| D | 2024-06-17 | BTAI | Mehta Vimal | CEO, Pres, 10% | S - Sale+OE | $1.28 | -2,134 | 7,735,040 | 0% | -$2,739 | |||||
| DM | 2024-06-04 | BTAI | Mehta Vimal | CEO, Pres, 10% | S - Sale+OE | $0.28 | -1,427,494 | 7,731,065 | -16% | -$405,135 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |